The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback